--- case_id: "3163" title: "Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Non-Arteritic Anterior Ischemic Optic Neuropathy Products Liability Litigation" research_checked: "2026-10-28" research_level: "documents" screening_approved: false settlement_availability: "not verified" care_availability: "not confirmed" --- # GLP-1 medicines & vision injuries MDL 3163 ## What this matter is about This is the separate GLP-1 proceeding concerning alleged non-arteritic anterior ischemic optic neuropathy (NAION), rather than the gastrointestinal MDL. The court document describes plaintiffs’ vision-injury allegations; clinical findings and individual causation need professional review. Basis: [Court source](https://www.paed.uscourts.gov/sites/paed/files/mdl-orders/25md3163_cm-ord_12.pdf). ## Verified index information - **Full title:** Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Non-Arteritic Anterior Ischemic Optic Neuropathy Products Liability Litigation - **District:** PAE - **Master docket:** 2:25-md-3163 - **Judge:** Marston, Karen S. - **Index report date:** 2026-10-01 - **Report relationship:** Listed in this report - [JPML report](https://www.jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_By_MDL_Type-October-1-2026.pdf#page=5) ## Preparation roadmap This is a preparation path, not a court schedule or a promise of a payout. 1. **Understand the matter.** Read the case overview and inspect its official sources. Keep allegations separate from findings. 2. **Explore your connection.** Use optional preparation questions. Interest in a matter is not proof of a claim. 3. **Build your record trail.** Product, medicine or device identity, if known. Add only what you already know or can verify. 4. **Make room for care.** Discuss health concerns independently of any legal claim. Clinical decisions belong with your care team. 5. **Choose professional review.** Start with your existing lawyer if represented. A lawyer reviews deadlines, jurisdiction and any filing or settlement options. ## Existing records that may help - Product, medicine or device identity, if known - An approximate timeline and existing receipts or records - Existing clinical reports and treating-team information ## Care information — separate from legal eligibility ### Eye-care review An eye-care professional can review existing vision concerns and reports. NEI explains how to find an eye doctor and check coverage. This is access information, not a determination that a medicine caused an eye condition. - Which eye reports and medicine records should I bring? - Which clinician should review my particular concern? General information: [NEI: finding an eye doctor](https://www.nei.nih.gov/eye-health-information/healthy-vision/finding-eye-doctor). This does not establish product-specific causation or an available appointment. Care may be accessed independently of a lawsuit. Provider fit, licensure, location, insurance, price and appointment availability have not been confirmed. Settlefy does not prescribe treatment, order tests, promise a cure or recommend stopping medication. Optional OPHealth: user-selected signed reports and measurements can be copied for private review. This is not a booked appointment, provider referral or ongoing medical monitoring. No record is sent to a lawyer through that connection. ## Research material and provenance ### IN THE UNITED STATES DISTRICT COURT - [Original source](https://www.paed.uscourts.gov/sites/paed/files/mdl-orders/25md3163_cm-ord_12.pdf) - Access: Retrieved and text-extracted; current legal interpretation still needs professional review - Retrieved: 2026-10-28T23:20:23.250Z - SHA-256: b014db779d4d193aa8dcf9109d2111e51604c93e4d560989aa5711545442bf90 - Text inspection: first 8 PDF pages; attachments or later pages may not be covered. ### Case 2:25-md-03163-KSM Document 67 Filed 03/16/26 Page 1 of 2 - [Original source](https://www.paed.uscourts.gov/sites/paed/files/mdl-orders/25md3163_cm-ord_6.pdf) - Access: Discovered official link; live retrieval or full review not completed - Retrieval date: not verified ### MDL 3163 In Re: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION) Products Liability Litigation | Eastern District of Pennsylvania | United States District Court - [Original source](https://www.paed.uscourts.gov/mdl/mdl-3163-re-glucagon-peptide-1-receptor-agonists-glp-1-ras-non-arteritic-anterior-ischemic-optic) - Access: Discovered official link; live retrieval or full review not completed - Retrieval date: not verified ### Case 2:25-md-03163-KSM  Document 59  Filed 03/06/26  Page 1 of 2 - [Original source](https://www.paed.uscourts.gov/sites/paed/files/mdl-orders/25md3163_sched-ord_1_amd.pdf) - Access: Discovered official link; live retrieval or full review not completed - Retrieval date: not verified ### Case 2:25-md-03163-KSM  Document 22  Filed 01/26/26  Page 1 of 2 - [Original source](https://www.paed.uscourts.gov/sites/paed/files/mdl-orders/25md3163_sched-ord_1.pdf) - Access: Discovered official link; live retrieval or full review not completed - Retrieval date: not verified ## Research gaps and professional review - Verify the operative complaint, later amendments and current court orders. - Verify any settlement notice, administrator, release, deadline and currently open intake. - Obtain current counsel-approved screening criteria; no eligibility rules are approved here. - Have qualified clinicians review any clinical mapping; general care sources are not case criteria. ## Updates [Live case page and source-update coverage](https://settlefy.com/litigation/3163#case-updates). Source checks run every six hours; most matters have directory-only monitoring. This file is a dated research brief, not an automatically updated court docket. ## Your next step [Explore the preparation questions](https://settlefy.com/my-settlefy?case=3163). Nothing is filed or sent to a firm automatically.